A Plus Biotechnology , Ltd. Net Tangible Assets

As of the most recent data (March 2026), 6918.TWO shows a net tangible assets of $1.1B. That compares with $840M in the prior-year period — up 35.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6918.TWO's net tangible assets is now $1.1B (was $840M) — a 35.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether A Plus Biotechnology , Ltd. is outperforming or lagging.

Tracking 6918.TWO's net tangible assets over time shows whether A Plus Biotechnology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1B That compares with $840M in the prior-year period — up 35.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has A Plus Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $1.1B) with ownership activity and broader fundamentals.